NBY
NovaBay Pharmaceuticals (NBY)
$71
About NovaBay Pharmaceuticals (NBY)
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase, CelleRx, and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.
Details
Daily high
$0.76
Daily low
$0.68
Price at open
$0.71
52 Week High
$9.08
52 Week Low
$0.36
Market cap
3.6M
Dividend yield
0.00%
Volume
184,236
Avg. volume
535,236
P/E ratio
-.02
NovaBay Pharmaceuticals News
Details
Daily high
$0.76
Daily low
$0.68
Price at open
$0.71
52 Week High
$9.08
52 Week Low
$0.36
Market cap
3.6M
Dividend yield
0.00%
Volume
184,236
Avg. volume
535,236
P/E ratio
-.02